Ad hoc announcement pursuant to Art. 53 LR Invitation to Novartis Extraordinary General Meeting on September 15, 2023, and Shareholder Information Brochure issued Sandoz Listing Prospectu… Read More

Sandoz, a pharmaceutical company that is proposed to be spun off from Novartis, hosted its first Capital Markets Day (CMD) in New York City to present its growth plans as a standalone compan… Read More

Basel: Sandoz has announced that the US Food and Drug Administration (USFDA) has approved a citrate-free high-concentration formulation (HCF) of its biosimilar Hyrimoz (adalimumab-adaz) inje… Read More

Zurich: Novartis has formally launched its new share buyback programme where it could spend up to 10 billion Swiss francs ($10.90 billion) repurchasing its shares over the next three years.T… Read More

Futures Trade In Narrow Range Ahead Of Tech Giant Earnings US equity futures erased modest earlier gains and traded modestly in the red, after rebounding from session lows as th… Read More

– In April 2021, Novartis AG (Sandoz) signed an agreement with Bio-Thera Solutions (China) to commercialize BAT1706 (proposed bevacizumab biosimilar by Bio-Thera Solutions) in the US… Read More

Buy Now According to the report analysis, ‘Asia Pacific Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimmune Disease, Blood… Read More

51-week clinical study compared Sandoz proposed biosimilaradalimumab with reference medicine Humira®* in patients with moderate-to-severe psoriasis1 Sandoz proposed biosimilaradalimumab… Read More

Generic Injectables Market: Introduction   According to the report, the global generic injectables market was valued at US$ 83.09 Bn in 2020 and is projected to expand at a CAGR of… Read More

Sandoz, a Novartis division and a global leader in biosimilars, announced that it has entered into a global commercialization agreement for a proposed natalizumab biosimilar. The medicine is… Read More

New Delhi: Vaccine refrigeration systems provider B Medical Systems plans to set up a facility in India by March 2021 and is in talks with top global vaccine manufacturers to provide technol… Read More

“Orlistat Market– Global Industry Dynamics 2019-20, Trends and Forecast, 2021–2028” is an upcoming market research report added by the analysts at Industry Probe. The… Read More

Rapture Ready End Times News1 Apr 2020Published on: April 1, 2020 by RRadmin7Report: FBI warned of Chinese researchers transporting disease samples in US before coronavirusAn… Read More

Biotech is one of the riskiest sectors – but it’s also one of the most profitable. As an investor, it’s important to keep the necessity of these companies’ products i… Read More

One season winds down, another offers hints of a beginning. I am afraid that both the regular Weekly Roundup as well as regular postings have lately been interrupted by some domestic issues… Read More